Stocks
Shire plcSHPG
NASDAQHealthcareBiotechnology$179.20+0.00%
A biopharmaceutical company focused on treatments for rare diseases and specialty conditions, with key franchises in immunology, hematology, neuroscience, and genetic disorders. Its portfolio historically included therapies such as Vyvanse for ADHD and a range of products targeting hereditary angioe...
Market Cap: $052W Range: $123.73 – $182.47
Congressional Interest in Shire plc (SHPG)
11 members of Congress have disclosed 50 trades in Shire plc (SHPG), a Healthcare company. The buy/sell breakdown shows 31 purchases versus 17 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
11
Buys
31
Sells
17
Who in Congress Is Trading SHPG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-06-05 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2021-05-02 | MICHAEL T. MCCAUL | buy | $1K – $15K |